Evaluation of AGN-150998 in Exudative Age-related Macular Degeneration (AMD)

Clinical trial NCT01397409 · COMPLETED

Trial details

NCT number: NCT01397409
Sponsor: Allergan
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Age-related Macular Degeneration

Start date: 2011-09-01
Primary completion: 2014-03-31
Enrollment: 271

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.